Mortality risk is associated with disease activity in patients with Sjögren disease: a South Australian retrospective cohort study

OBJECTIVES: To evaluate the overall risk of mortality in Sjögren disease (SjD) and its relationship to baseline systemic disease activity in an Australian population. METHODS: This retrospective cohort study included 241 patients fulfilling 2016 ACR-EULAR classification criteria from the South Australian (SA) Sjögren Disease Registry with up to 30 years of follow-up. Baseline data included patient demographics, serology and disease activity (ESSDAI). Analysis included the standardised mortality ratio (SMR) and cox regression. RESULTS: Patients were predominantly female (217, 89%), with a median age at diagnosis of 58 years. Most had oral (99%) and ocular (97%) dryness, Ro/La autoantibodies (193, 80%) and rheumatoid factor (RF, 142, 61%). ESSDAI scores were grouped into low (<5), n = 121 (50%); moderate (5-13), n = 92 (38%); and high (>13), n = 28 (12%). Mortality was not increased compared to the SA population (SMR 1.18, 95%CI 0.90, 1.54). Patients with high baseline ESSDAI disease activity had a four-fold mortality risk compared to patients with low disease activity (HR 3.9, 95%CI 1.7, 8.7). Moderate to high activity in ESSDAI renal or pulmonary domains, and any activity in the biological domain, contributed to this increased mortality. Rheumatoid factor positivity was independently associated with mortality risk (HR 2.2, 95%CI 1.0, 4.7). Causes of death were cardiovascular, pulmonary, infections, cancer, and kidney disease. CONCLUSION: High disease activity at baseline, including moderate to high activity in renal and pulmonary and any activity in biological domain, and positive rheumatoid factor are associated with increased mortality risk in SjD patients, underscoring the systemic impact of this disease.

Authors

Institutions

Publication Details

Journal
Rheumatology
Published
2026-11-17
DOI
https://doi.org/10.1093/rheumatology/keag644
Primary Topic
Salivary Gland Disorders and Functions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mortality risk is associated with disease activity in patients with Sjögren disease: a South Australian retrospective cohort study

Sue Lester, Maureen Rischmueller, Chandra Kirana, Sarah Downie Doyle
Rheumatology
Salivary Gland Disorders and Functions
article

Mortality risk is associated with disease activity in patients with Sjögren disease: a South Australian retrospective cohort study

Sue Lester, Maureen Rischmueller, Chandra Kirana, Sarah Downie Doyle
article en

Abstract

OBJECTIVES: To evaluate the overall risk of mortality in Sjögren disease (SjD) and its relationship to baseline systemic disease activity in an Australian population. METHODS: This retrospective cohort study included 241 patients fulfilling 2016 ACR-EULAR classification criteria from the South Australian (SA) Sjögren Disease Registry with up to 30 years of follow-up. Baseline data included patient demographics, serology and disease activity (ESSDAI). Analysis included the standardised mortality ratio (SMR) and cox regression. RESULTS: Patients were predominantly female (217, 89%), with a median age at diagnosis of 58 years. Most had oral (99%) and ocular (97%) dryness, Ro/La autoantibodies (193, 80%) and rheumatoid factor (RF, 142, 61%). ESSDAI scores were grouped into low (<5), n = 121 (50%); moderate (5-13), n = 92 (38%); and high (>13), n = 28 (12%). Mortality was not increased compared to the SA population (SMR 1.18, 95%CI 0.90, 1.54). Patients with high baseline ESSDAI disease activity had a four-fold mortality risk compared to patients with low disease activity (HR 3.9, 95%CI 1.7, 8.7). Moderate to high activity in ESSDAI renal or pulmonary domains, and any activity in the biological domain, contributed to this increased mortality. Rheumatoid factor positivity was independently associated with mortality risk (HR 2.2, 95%CI 1.0, 4.7). Causes of death were cardiovascular, pulmonary, infections, cancer, and kidney disease. CONCLUSION: High disease activity at baseline, including moderate to high activity in renal and pulmonary and any activity in biological domain, and positive rheumatoid factor are associated with increased mortality risk in SjD patients, underscoring the systemic impact of this disease.

Rheumatology
Basil Hetzel Institute (AU), Queen Elizabeth Hospital (AU), The University of Adelaide (AU)
Salivary Gland Disorders and Functions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon